Trade Ideas

Actionable trade ideas with defined risk and time horizons.

Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.

Articles

13,878 total articles

Modine: Betting on a Multi-Year Data Center Cooling Run

Modine: Betting on a Multi-Year Data Center Cooling Run

Modine is transitioning from a diversified thermal supplier into a focused data-center cooling play after a headline hyperscaler contract and a planned spinoff of its lower-margin unit. The numbers show surging demand and improving profitability, but valuation is rich. This trade idea sizes a tactical long around the current breakout, with a define…

Buy the Dip: BitMine (BMNR) as a Crypto-Treasury Rebound Play

Buy the Dip: BitMine (BMNR) as a Crypto-Treasury Rebound Play

BitMine Immersion Technologies has been sold off with the broader crypto decline, leaving the share price at $17.10 and valuation below $10B. The company recently raised ~$274M via a preferred-stock sale, is accelerating Ethereum accumulation and staking, and trades below its near-term moving averages with an RSI in the high 30s. This trade idea la…

Ride the Nvidia Spark - Tactical Long on Marvell Into AI Infra Spend

Ride the Nvidia Spark - Tactical Long on Marvell Into AI Infra Spend

Marvell surged after high-profile endorsements and upbeat guidance. The stock is extended but still actionable as a momentum swing: entry at $298.67, target $335.00, stop $275.00. The trade leans on continued AI data-center spending, optical interconnect demand and strategic investments from Nvidia and partners, balanced against a premium valuation…

Buy SentinelOne on the Dip: Cheap Exposure to AI-Driven Cybersecurity

Buy SentinelOne on the Dip: Cheap Exposure to AI-Driven Cybersecurity

SentinelOne ($S) is trading at ~$15.70 with a market cap near $5.38B after a sharp post-earnings selloff. The company still produces positive free cash flow, has a large addressable market in AI-enabled endpoint and agent security, and is trading at roughly 5x EV/sales against a FY27 revenue guide of $1.195-$1.205B. This trade idea lays out an acti…

Flex: Buy the AI Supply-Chain Play — Long into AI Server Buildout

Flex: Buy the AI Supply-Chain Play — Long into AI Server Buildout

Flex sits at the intersection of contract manufacturing, regulated medical assembly and cloud/power infrastructure hardware. With partnerships to localize AI server manufacturing and a solid free cash flow base, the stock looks set to capture durable AI supply-chain demand. This trade idea lays out an actionable long with entry, stop and target, a …

Buy NUVB: Ibtrozi Launch + Rating Upgrade Offers Asymmetric Upside

Buy NUVB: Ibtrozi Launch + Rating Upgrade Offers Asymmetric Upside

Nuvation Bio (NUVB) is a clinical-stage oncology biotech transitioning to commercialization with the Ibtrozi launch. The market is pricing in execution risk after recent investor lawsuits and insider sales, but the balance sheet, improving technical picture, and a concentrated short interest create a high-reward opportunity. This trade targets a me…

Buy the Dip in ServiceNow: SaaS Angst Creates a High-Reward Entry

Buy the Dip in ServiceNow: SaaS Angst Creates a High-Reward Entry

ServiceNow (NOW) pulled back into the low $110s after a broad SaaS sell-off. Fundamentals remain intact: $115.99B market cap, $4.63B in free cash flow, ROE ~15% and low leverage. Short-term sentiment swung negative then reversed around early June; that momentum reset creates an attractive long entry at $113.00 with a $145.00 target and $98.00 stop.…

Why Broadcom's Pullback Is a Buying Opportunity, Not a Breakdown

Why Broadcom's Pullback Is a Buying Opportunity, Not a Breakdown

Broadcom (AVGO) has pulled back sharply, but beneath the headline volatility the company retains durable secular advantages, strong free cash flow, and enterprise exposure that should support a recovery. This is a tactical long trade that aims to capture mean reversion into value and upcoming catalysts while keeping position risk-defined.

enGene Therapeutics: Oversold Biotech — A Risk-Adjusted Bounce Trade

enGene Therapeutics: Oversold Biotech — A Risk-Adjusted Bounce Trade

enGene (ENGN) has plunged from a $12.25 peak to under $2. The balance sheet is thin and the company burns cash, but the stock is deeply oversold (RSI 28.5) and trading at a sub-0.4 P/B with an enterprise value below $100M. For traders willing to accept biotech binary risk, a disciplined long with a tight stop and a clear time horizon can offer asym…

Atour Lifestyle: Dividend-Backed Recovery with Room to Run

Atour Lifestyle: Dividend-Backed Recovery with Room to Run

Atour (ATAT) trades below recent highs after a pullback. The company is executing rapid hotel expansion, posted double-digit revenue growth, and just reinforced shareholder returns via dividends and buybacks. A tactical long entry around $33.00 offers an asymmetric risk/reward to $40.00 with a $31.00 stop on a mid-term (45 trading days) horizon.